Ben Schilling
Senior Manager, Process Development Caribou Biosciences
Ben Schilling is a Senior Manager in Process Development at Caribou Biosciences, where he leads efforts in developing allogeneic CAR-T cell therapies. With experience spanning Eureka Therapeutics and NantBioscience, Ben has built deep expertise in clinical T-cell manufacturing, drug discovery, and process development. He holds a B.S. in Chemical Engineering from UCLA and brings a strong background in process optimization, analytical methods, and translating early-stage therapies to scalable manufacturing platforms.
Seminars
Wednesday 15th July 2026
From Manufacturing Data to Predictive Insight: Leveraging Process Data to Drive Allogeneic Cell Therapy Development
3:40 pm
- Structuring data capture systems and databases to aggregate clinical manufacturing runs and enable meaningful analysis of process performance trends
- Applying aggregated data to develop predictive models for process yield, cell expansion, unit operation recovery, and process timing
- Identifying critical process parameters and performance gaps through data analysis to guide optimization and improve robustness
